Revvity, Inc. (NYSE:RVTY) Shares Sold by Forsta AP Fonden

Forsta AP Fonden decreased its holdings in Revvity, Inc. (NYSE:RVTY) by 8.4% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 24,100 shares of the company’s stock after selling 2,200 shares during the quarter. Forsta AP Fonden’s holdings in Revvity were worth $2,527,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Rothschild Investment LLC acquired a new position in shares of Revvity in the 2nd quarter valued at approximately $25,000. Logan Capital Management Inc. acquired a new stake in Revvity in the fourth quarter valued at $37,000. Family Firm Inc. acquired a new stake in Revvity in the second quarter valued at $43,000. Parallel Advisors LLC bought a new position in Revvity during the 4th quarter valued at $47,000. Finally, EntryPoint Capital LLC acquired a new position in Revvity during the 1st quarter worth $48,000. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently commented on RVTY shares. TD Cowen increased their price target on shares of Revvity from $130.00 to $141.00 and gave the stock a “buy” rating in a research report on Tuesday, July 30th. Leerink Partnrs upgraded Revvity to a “strong-buy” rating in a research report on Monday, July 8th. Jefferies Financial Group upped their price target on Revvity from $115.00 to $125.00 and gave the company a “hold” rating in a research report on Monday, July 29th. Wells Fargo & Company began coverage on shares of Revvity in a report on Tuesday, August 27th. They issued an “equal weight” rating and a $130.00 price objective for the company. Finally, Barclays increased their target price on shares of Revvity from $115.00 to $125.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 30th. Eight analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $126.00.

Insider Transactions at Revvity

In related news, insider Joel S. Goldberg sold 3,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $117.86, for a total transaction of $412,510.00. Following the sale, the insider now owns 33,400 shares of the company’s stock, valued at $3,936,524. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 0.60% of the company’s stock.

Revvity Stock Up 1.6 %

RVTY opened at $122.03 on Monday. The stock’s 50 day moving average price is $117.37 and its 200 day moving average price is $110.06. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.27 and a quick ratio of 1.98. The stock has a market cap of $15.06 billion, a P/E ratio of 100.85, a P/E/G ratio of 2.87 and a beta of 1.05. Revvity, Inc. has a 12 month low of $79.50 and a 12 month high of $128.15.

Revvity (NYSE:RVTY) last issued its quarterly earnings results on Monday, July 29th. The company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.12 by $0.10. The company had revenue of $691.70 million for the quarter, compared to analyst estimates of $690.33 million. Revvity had a return on equity of 7.34% and a net margin of 6.26%. The company’s quarterly revenue was down 2.5% compared to the same quarter last year. During the same period last year, the company earned $1.21 earnings per share. As a group, research analysts predict that Revvity, Inc. will post 4.75 earnings per share for the current year.

Revvity Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 8th. Stockholders of record on Friday, October 18th will be paid a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.23%. The ex-dividend date is Friday, October 18th. Revvity’s dividend payout ratio is currently 23.14%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.